Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant

Yundeok Kim, Sulhee Yoon, Soo Jeong Kim, Jin Seok Kim, Jun Won Cheong, Yoo Hong Min

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) vary considerably. The decision of which of these options to choose is complex and depends on both clinical and molecular variables as well as the availability and histocompatability of donor stem cells. So far there is no clear explanation on whether the expression of myeloperoxidase (MPO) relates to the prognosis of AML. Materials and Methods: We retrospectively analyzed the prognostic significance of the MPO expression in the 140 patients with diagnosed AML treated at a single institution. Results: In our study, MPO expression was associated with disease-free survival (DFS) and transplant was beneficial to overcome a negative prognostic effect of MPO-negative at diagnosis based upon the result that the DFS in patients received transplants are not significant between the MPO-positive group and MPO-negative group although DFS in all patients was different according to MPO expression. Conclusion: MPO expression at diagnosis helps to choose therapy for each AML patient and can differentiate AML patients who need transplantation.

Original languageEnglish
Pages (from-to)530-536
Number of pages7
JournalYonsei medical journal
Volume53
Issue number3
DOIs
Publication statusPublished - 2012 May 1

Fingerprint

Acute Myeloid Leukemia
Peroxidase
Transplants
Disease-Free Survival
Hematopoietic Stem Cell Transplantation
Stem Cells
Transplantation
Tissue Donors

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, Yundeok ; Yoon, Sulhee ; Kim, Soo Jeong ; Kim, Jin Seok ; Cheong, Jun Won ; Min, Yoo Hong. / Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant. In: Yonsei medical journal. 2012 ; Vol. 53, No. 3. pp. 530-536.
@article{0d628a0a2c684c37a8dc2c89c5ffa87b,
title = "Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant",
abstract = "Purpose: Despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) vary considerably. The decision of which of these options to choose is complex and depends on both clinical and molecular variables as well as the availability and histocompatability of donor stem cells. So far there is no clear explanation on whether the expression of myeloperoxidase (MPO) relates to the prognosis of AML. Materials and Methods: We retrospectively analyzed the prognostic significance of the MPO expression in the 140 patients with diagnosed AML treated at a single institution. Results: In our study, MPO expression was associated with disease-free survival (DFS) and transplant was beneficial to overcome a negative prognostic effect of MPO-negative at diagnosis based upon the result that the DFS in patients received transplants are not significant between the MPO-positive group and MPO-negative group although DFS in all patients was different according to MPO expression. Conclusion: MPO expression at diagnosis helps to choose therapy for each AML patient and can differentiate AML patients who need transplantation.",
author = "Yundeok Kim and Sulhee Yoon and Kim, {Soo Jeong} and Kim, {Jin Seok} and Cheong, {Jun Won} and Min, {Yoo Hong}",
year = "2012",
month = "5",
day = "1",
doi = "10.3349/ymj.2012.53.3.530",
language = "English",
volume = "53",
pages = "530--536",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant. / Kim, Yundeok; Yoon, Sulhee; Kim, Soo Jeong; Kim, Jin Seok; Cheong, Jun Won; Min, Yoo Hong.

In: Yonsei medical journal, Vol. 53, No. 3, 01.05.2012, p. 530-536.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant

AU - Kim, Yundeok

AU - Yoon, Sulhee

AU - Kim, Soo Jeong

AU - Kim, Jin Seok

AU - Cheong, Jun Won

AU - Min, Yoo Hong

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Purpose: Despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) vary considerably. The decision of which of these options to choose is complex and depends on both clinical and molecular variables as well as the availability and histocompatability of donor stem cells. So far there is no clear explanation on whether the expression of myeloperoxidase (MPO) relates to the prognosis of AML. Materials and Methods: We retrospectively analyzed the prognostic significance of the MPO expression in the 140 patients with diagnosed AML treated at a single institution. Results: In our study, MPO expression was associated with disease-free survival (DFS) and transplant was beneficial to overcome a negative prognostic effect of MPO-negative at diagnosis based upon the result that the DFS in patients received transplants are not significant between the MPO-positive group and MPO-negative group although DFS in all patients was different according to MPO expression. Conclusion: MPO expression at diagnosis helps to choose therapy for each AML patient and can differentiate AML patients who need transplantation.

AB - Purpose: Despite extensive study, the use of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia (AML) vary considerably. The decision of which of these options to choose is complex and depends on both clinical and molecular variables as well as the availability and histocompatability of donor stem cells. So far there is no clear explanation on whether the expression of myeloperoxidase (MPO) relates to the prognosis of AML. Materials and Methods: We retrospectively analyzed the prognostic significance of the MPO expression in the 140 patients with diagnosed AML treated at a single institution. Results: In our study, MPO expression was associated with disease-free survival (DFS) and transplant was beneficial to overcome a negative prognostic effect of MPO-negative at diagnosis based upon the result that the DFS in patients received transplants are not significant between the MPO-positive group and MPO-negative group although DFS in all patients was different according to MPO expression. Conclusion: MPO expression at diagnosis helps to choose therapy for each AML patient and can differentiate AML patients who need transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84859749866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859749866&partnerID=8YFLogxK

U2 - 10.3349/ymj.2012.53.3.530

DO - 10.3349/ymj.2012.53.3.530

M3 - Article

C2 - 22476996

AN - SCOPUS:84859749866

VL - 53

SP - 530

EP - 536

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -